Mónica de Abadal is an accomplished Global Medical Affairs Executive Leader with a proven history of upscaling organizational capabilities , successful product launches in the US, Europe and Australia. Driven by improving patient care, Monica brings more than two decades of experience in the biopharmaceutical industry, transforming organizations, through growth and sophistication of medical affairs functions, the development of adept and imaginative teams, and the promotion of a forward-thinking culture that emphasizes strong interdepartmental collaboration. She is currently leading Medical Affairs International (WW, ex-US) at CSL Behring, where she brings her executive medical and biopharmaceutical extensive experience across geographies and therapeutic areas.

As SVP, Medical Affairs, North America (2021-2024), Monica transformed the medical organization, establishing medical affairs as a key pillar, enhancing strategic direction, boosting team efficiency, improved operational and scientific excellence, with measurable impact internally and externally. She also led worldwide medical integration of acquired companies, accomplishing full integration within 3 months and launched multiple assets and indications across solid and hematological tumors and rare diseases in the US.

As VP Global Medical Excellence (2020 -2021) she spearheaded medical transformation, upgraded worldwide capabilities,  including the design and implementation of a new operating model, resulting in successful health authority inspections, and oversaw 20+ clinical studies phase II-IV  and 100+ independent investigator studies.

Monica spent 7 years in Australia as Medical Director, working mainly in Rare Diseases and Oncology.

As President of MAPS EMEA, Monica launched the organization in Europe and increased membership from 300 to 2000 members. 

Monica is committed to fostering an environment where people's growth and development are her priorities. She is a mentor to several pharmaceutical executives across geographies.